Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS study.

Al-Roughani, Raed; Zakaria, Magd; Cupler, Edward J; Taha, Karim

Al-Roughani, Raed; Zakaria, Magd; Cupler, Edward J; Taha, Karim.

Afiliação

Al-Roughani R; Division of Neurology, Amiri Hospital, Sharq, Kuwait.
Zakaria M; Department of Neurology, Ain Shams University, Cairo, Egypt.
Cupler EJ; Division of Neurology, Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Taha K; Neurology and Immunology Medical Affairs, EMEA Region, Merck Serono Middle East FZ-Ltd., Dubai, United Arab Emirates.

Front Neurol ; 14: 1257455, 2023.

Article em En | MEDLINE | ID: mdl-38090266

Palavras-chave

Rebif; adherence; patient support programme; relapsing multiple sclerosis; subcutaneous interferon beta-1a

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Neurol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Kuait

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Neurol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Kuait